Cholesterol Efflux Capacity and Atherosclerosis

被引：0
|
作者：
Asleh, Rabea [1 ]
Levy, Andrew P. [1 ]
Blum, Shany [1 ]
机构：
[1] Technion Israel Inst Technol, Fac Med, Haifa, Israel
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2011年 / 364卷 / 15期
关键词：
CARDIOVASCULAR-DISEASE; INDIVIDUALS; GENOTYPE; HDL;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1473 / 1473
页数：1
相关论文
共 50 条
  • [21] Significance of the percentage of cholesterol efflux capacity and total cholesterol efflux capacity in patients with or without coronary artery disease
    Norimatsu, Kenji
    Kuwano, Takashi
    Miura, Shin-ichiro
    Shimizu, Tomohiko
    Shiga, Yuhei
    Suematsu, Yasunori
    Miyase, Yuiko
    Adachi, Sen
    Nakamura, Ayumi
    Imaizumi, Satoshi
    Iwata, Atsushi
    Nishikawa, Hiroaki
    Uehara, Yoshinari
    Saku, Keijiro
    HEART AND VESSELS, 2017, 32 (01) : 30 - 38
  • [22] Lack of Correlation of Plasma HDL With Fecal Cholesterol and Plasma Cholesterol Efflux Capacity Suggests Importance of HDL Functionality in Attenuation of Atherosclerosis
    Srivastava, Neelam
    Cefalu, Angelo B.
    Averna, Maurizio
    Srivastava, Rai A. K.
    FRONTIERS IN PHYSIOLOGY, 2018, 9
  • [23] Cholesterol mass efflux capacity and risk of peripheral artery disease: The Multi-Ethnic Study of Atherosclerosis
    Garg, Parveen K.
    Jorgensen, Neal W.
    McClelland, Robyn L.
    Allison, Matthew
    Stein, James H.
    Yvan-Chavret, Laurent
    Talle, Alan R.
    Shea, Steven
    ATHEROSCLEROSIS, 2020, 297 : 81 - 86
  • [24] Impaired HDL cholesterol efflux capacity in systemic lupus erythematosus patients is related to subclinical carotid atherosclerosis
    Sanchez-Perez, Hiurma
    Quevedo-Abeledo, Juan Carlos
    De Armas-Rillo, Laura
    Rua-Figueroa, Inigo
    Tejera-Segura, Beatriz
    Armas-Gonzalez, Estefania
    Machado, Jose David
    Garcia-Dopico, Jose A.
    Jimenez-Sosa, Alejandro
    Rodriguez-Lozano, Carlos
    Diaz-Gonzalez, Federico
    Gonzalez-Gay, Miguel A.
    Ferraz-Amaro, Ivan
    RHEUMATOLOGY, 2020, 59 (10) : 2847 - 2856
  • [25] Cholesterol efflux capacity in humans with psoriasis is inversely related to non-calcified burden of coronary atherosclerosis
    Salahuddin, Taufiq
    Natarajan, Balaji
    Playford, Martin P.
    Joshi, Aditya A.
    Teague, Heather
    Masmoudi, Youssef
    Selwaness, Mariana
    Chen, Marcus Y.
    Bluemke, David A.
    Mehta, Nehal N.
    EUROPEAN HEART JOURNAL, 2015, 36 (39) : 2662 - 2665
  • [26] High-density Lipoprotein Cholesterol Efflux Capacity is not associated with Atherosclerosis and Cardiovascular Events: the CODAM Study
    Josefs, Tatjana
    Wouters, Kristiaan
    Tietge, Uwe J.
    Dullaart, Robin P.
    van der Kallen, Carla J.
    Stehouwer, Coen D.
    Schalkwijk, Casper G.
    Goldberg, Ira J.
    Fisher, Edward A.
    van Greevenbroek, Marleen M.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38
  • [27] High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives
    Adorni, Maria Pia
    Ronda, Nicoletta
    Bernini, Franco
    Zimetti, Francesca
    CELLS, 2021, 10 (03) : 1 - 37
  • [28] CHOLESTEROL EFFLUX CAPACITY IS INVERSELY ASSOCIATED WITH SEVERITY OF CAROTID ATHEROSCLEROSIS AND INCREASES WITH TIME SINCE CEREBROVASCULAR EVENT
    Doonan, R. J.
    Hafiane, A.
    Gorgui, J.
    Genest, J.
    Daskalopoulou, S. S.
    CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (10) : S269 - S269
  • [29] Cholesterol Efflux Capacity is Inversely Associated with Severity of Carotid Atherosclerosis and Increases with Time Since Cerebrovascular Event
    Doonan, R. J.
    Hafiane, A.
    Gorgui, J.
    Genest, J.
    Daskalopoulou, S. S.
    STROKE, 2013, 44 (12) : E176 - E176
  • [30] TUDCA alleviates atherosclerosis by inhibiting AIM2 inflammasome and enhancing cholesterol efflux capacity in macrophage
    Wang, Xuyang
    Zhang, Yuesheng
    Du, Luping
    Jiang, Zhengchen
    Guo, Yan
    Wang, Kai
    Zhou, Yijiang
    Yin, Xiang
    Guo, Xiaogang
    ISCIENCE, 2024, 27 (06)
12345